Intestinal microflora and body mass index during the first three years of life: an observational study

Carl Vael1, Stijn L Verhulst2, Vera Nelen3

  • 1Department of Microbiology, University of Antwerp, Antwerp, Belgium.

Gut Pathogens
|May 25, 2011
PubMed

Insights

Infant gut bacteria like Bacteroides fragilis and Staphylococcus influence later obesity risk. High Bacteroides fragilis and low Staphylococcus in early infancy are linked to increased Body Mass Index Standard Deviation Score (BMI SDS).

Area of Science:

  • Microbiology
  • Pediatrics
  • Nutritional Science

Background:

  • Intestinal microflora plays a crucial role in host energy balance.
  • Emerging research highlights the influence of gut microbiota on obesity.
  • Understanding early-life microbial composition is key to metabolic health.

Purpose of the Study:

  • To investigate the relationship between intestinal microflora and Body Mass Index Standard Deviation Score (BMI SDS) in infants.
  • To identify specific bacterial genera associated with BMI SDS during the first three years of life.
  • To explore potential microbial targets for obesity prevention in early childhood.

Main Methods:

  • Prospective study involving 138 infants.
  • Faecal samples collected at 3, 26, and 52 weeks of age.
  • Culture of 6 bacterial genera and assessment of Body Mass Index Standard Deviation Score (BMI SDS) between 1 and 3 years.

Main Results:

  • A positive correlation was observed between Bacteroides fragilis concentration and BMI SDS at 3 and 26 weeks.
  • Staphylococcus concentration showed a negative correlation with BMI SDS at 3 and 52 weeks.
  • A low Staphylococcus/Bacteroides fragilis ratio at 3 weeks was associated with a higher BMI SDS in early childhood.

Conclusions:

  • Elevated intestinal Bacteroides fragilis and reduced Staphylococcus in infants (3 weeks to 1 year) correlate with increased obesity risk.
  • These findings suggest potential microbial biomarkers for predicting childhood obesity.
  • Modulating the infant gut microbiome may offer novel strategies for obesity prevention.
Abstract

Related Concept Videos

Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Anatomy of the Intestines01:23

Anatomy of the Intestines

Although digestion of proteins, carbohydrates, and lipids may begin in the stomach, it is completed in the intestine. The absorption of nutrients, water, and electrolytes from food and drink also occurs in the intestine. The intestines can be divided into two structurally distinct organs—the small and large intestines.
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the small...
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
Introduction to the Human Microbiota01:22

Introduction to the Human Microbiota

Microorganisms colonize various regions of the human body, including the mouth, nasal passages, throat, stomach, intestines, urogenital tract, and skin. The total number of microbial cells is estimated to range from 10¹³ to 10¹⁴—comparable to, or exceeding, the number of human somatic cells. This host–microbiome relationship has led to the conceptualization of humans as supraorganisms, wherein microbial communities perform vital roles in development, immunity, and disease...
Microbiota Modulation by Antibiotics01:21

Microbiota Modulation by Antibiotics

Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...
Microbiota of the Stomach and Small Intestine01:27

Microbiota of the Stomach and Small Intestine

The human gastrointestinal (GI) tract is characterized by distinct physicochemical conditions that shape its microbial communities. Among these, the stomach presents a particularly challenging environment for microbial colonization due to its highly acidic pH, ranging from 1 to 3. This extreme acidity effectively limits microbial density. However, certain acid-tolerant microorganisms are capable of surviving in this niche. Notably, Helicobacter pylori can colonize the gastric mucosa,...